Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135912 · ClinicalTrials.gov registry record · Phase 2
Three-Arm Trial of Novel Treatment for Tinea Pedis
A Phase 2 study of Tinea Pedis, sponsored by South End Skin Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03135912 is a Phase 2 study of Tinea Pedis that has completed, run by South End Skin Care. The registered enrollment target is 90 participants, below the 317-participant average among 9 other Tinea Pedis trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03135912, a Phase 2 study of Tinea Pedis, has completed, sponsored by South End Skin Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a three-arm randomized controlled trial to assess the efficacy of an experimental treatment in the treatment of tinea pedis (athlete's foot). The experimental treatment will be tested against a vehicle control to determine efficacy and safety, and against an active comparator to evaluate the success of the treatment relative to an existing gold-standard treatment. Patients will be treated for four weeks, with their condition being assessed at the end of treatment and two weeks after the end of treatment. The primary endpoint for this study is effective treatment rate at the week 6 evaluation, defined as a mycological cure and minimal clinical signs \& symptoms. Secondary endpoints include safety and patient evaluation of treatment.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Terbinafine Hydrochloride
- DRUG Experimental Drug SESC 01
Study Locations (1)
Massachusetts
- Kuchnir Dermatology & Dermatologic Surgery - Milford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2017-01-03 |
| Est. Completion | 2017-08-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03135912
The ClinicalTrials.gov registry entry for NCT03135912 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 317-participant average among 9 other Tinea Pedis trials with a reported enrollment target (72% lower). The listed sponsor is South End Skin Care, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tinea Pedis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03135912 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03135912 about?
NCT03135912 is a clinical study titled "Three-Arm Trial of Novel Treatment for Tinea Pedis". This is a three-arm randomized controlled trial to assess the efficacy of an experimental treatment in the treatment of tinea pedis (athlete's foot). The experimental treatment will be tested against a vehicle control to determine efficacy and safety, and against an active comparator to evaluate the...
What is the current status of trial NCT03135912?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2017-01-03. Estimated completion is 2017-08-02.
What conditions does trial NCT03135912 study?
This clinical trial studies the following conditions: Tinea Pedis.
What interventions are being tested in trial NCT03135912?
The interventions under investigation include: Placebo (DRUG), Terbinafine Hydrochloride (DRUG), Experimental Drug SESC 01 (DRUG).
Who is sponsoring clinical trial NCT03135912?
This trial is sponsored by South End Skin Care, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03135912 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinea Pedis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
RECRUITING · Phase 2
-
A Study of Econazole Foam 1% in Athlete's Foot
COMPLETED · Phase 2
-
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
COMPLETED · Phase 1
-
Spread of Dermatophytes Among Families
COMPLETED
-
BE Study of Naftifine HCL
COMPLETED · Phase 3
-
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.